The landscape of dementia diagnosis has evolved radically with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams which will detect Alzheimer's pathology yrs prior to indicators arise. When these technological innovations represent exceptional progress in comprehension neurodegenerative co